Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Non-cash Items (2018 - 2024)

Historic Non-cash Items for TransMedics (TMDX) over the last 7 years, with Q4 2024 value amounting to $76.9 million.

  • TransMedics' Non-cash Items fell 5176.76% to $76.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $76.9 million, marking a year-over-year decrease of 5176.76%. This contributed to the annual value of $76.9 million for FY2024, which is 5176.76% down from last year.
  • TransMedics' Non-cash Items amounted to $76.9 million in Q4 2024, which was down 5176.76% from $159.3 million recorded in Q4 2023.
  • TransMedics' Non-cash Items' 5-year high stood at $159.3 million during Q4 2023, with a 5-year trough of $14.6 million in Q4 2021.
  • Over the past 5 years, TransMedics' median Non-cash Items value was $76.9 million (recorded in 2024), while the average stood at $81.9 million.
  • In the last 5 years, TransMedics' Non-cash Items soared by 80308.38% in 2022 and then tumbled by 5176.76% in 2024.
  • TransMedics' Non-cash Items (Quarter) stood at $26.7 million in 2020, then tumbled by 45.17% to $14.6 million in 2021, then soared by 803.08% to $132.1 million in 2022, then increased by 20.64% to $159.3 million in 2023, then plummeted by 51.77% to $76.9 million in 2024.
  • Its last three reported values are $76.9 million in Q4 2024, $159.3 million for Q4 2023, and $132.1 million during Q4 2022.